Now you know what makes you itch
27 May, 2013Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the sensation of itch.
Don’t breathe your way to worse cholesterol
20 May, 2013Academic researchers have found that breathing motor vehicle emissions triggers a change in high-density lipoprotein (HDL) cholesterol, altering its cardiovascular protective qualities so that it actually contributes to clogged arteries.
Developing a faster diagnosis of bacterial meningitis
22 April, 2013Using joint funding from the Paige Weatherspoon Foundation and the Macquarie University Office of Commercialisation, a team of researchers have recently made headway in developing a faster diagnosis for bacterial meningitis.
Rapid test device has global impact
15 April, 2013Two engineers have changed the way blood is collected and tested thanks to a world-first, fully integrated rapid test device, designed and developed in Australia.
Screening human blood for disease markers
25 March, 2013Researchers at The Scripps Research Institute in Florida have developed cutting-edge technology that can successfully screen human blood for disease markers. This tool may hold the key to better diagnosing and understanding today’s most pressing and puzzling health conditions, including autoimmune diseases.
Saliva test could detect early stages of HPV-linked oral cancer
14 March, 2013The University of Queensland has received a major funding boost to its development of a saliva test to diagnose the early stages of head and neck cancer linked to human papillomavirus (HPV).
Type 1 diabetes testing could become faster, cheaper
11 March, 2013Work by Perth researchers could revolutionise testing for type 1 diabetes around the world.
New blood test set to detect ‘forgotten’ women’s cancer
27 February, 2013Garvan researchers, in collaboration with The Gynaecologic Cancer Centre at Royal Hospital for Women, are developing the first-ever early detection test for ovarian cancer based on epigenetic changes that are associated with ovarian cancer risk.
UC researching new forms of tumour detection
11 February, 2013Researchers at the University of Canterbury are working on new forms of tumour detection in the hope of reducing the annual cancer toll.
Researchers identify enzyme involved in deadly brain tumours
25 January, 2013In a study published in Neuro-Oncology, researchers at Mayo Clinic identify an important association between the naturally occurring enzyme Kallikrein 6, also known as KLK6, and the malignant tumour glioblastoma multiforme.
Scientists pinpoint molecular signals that make some women prone to miscarriage
21 January, 2013Scientists have identified molecular signals that control whether embryos are accepted by the womb and appear to function abnormally in women who have suffered repeated miscarriages.
Potential new treatment for gastrointestinal cancers discovered
17 January, 2013Researchers have identified a complex of proteins that promotes the growth of some types of colon and gastric cancers, and shown that medications that block the function of this complex have the potential to be developed into a new treatment for these diseases.
Saliva glands may diagnose Parkinson’s disease
15 January, 2013 by Lauren DavisNew research from Mayo Clinic in Arizona and Banner Sun Health Research Institute suggests that testing a portion of a person’s saliva gland may be a way to diagnose the degenerative disorder Parkinson’s disease. The study will be presented at the American Academy of Neurology’s annual meeting in San Diego in March.
Alzheimer’s to be diagnosed online
10 January, 2013The early onset of Alzheimer’s disease could be detected using a simple online test, according to scientists from the Queensland Brain Institute (QBI) at The University of Queensland (UQ).
Researchers find new molecule to target in pancreatic cancer treatment
08 January, 2013Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95% of pancreatic cancer cases.
